Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure | Zendy

M. N. Sinkovа | Zendy; Л. К. Исаков | Zendy; T. V. Pepelyaeva | Zendy; N. I. Tarasov | Zendy; А. T. Teplyakov | Zendy; F. Yu. Mukharlyamov | Zendy

Open Access

Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

Author(s) -

M. N. Sinkovа,

Л. К. Исаков,

T. V. Pepelyaeva,

N. I. Tarasov,

А. T. Teplyakov,

F. Yu. Mukharlyamov

Publication year - 2015

Publication title -

cardiosomatics

Language(s) - English

Resource type - Journals

eISSN - 2658-5707

pISSN - 2221-7185

DOI - 10.26442/cs45131

Subject(s) - medicine , cardiology , levosimendan , inotrope , myocardial infarction , heart failure , percutaneous transluminal coronary angioplasty

The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class Killip, subjected to percutaneous transluminal coronary angioplasty.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research